Brand: Marco Pharma Int'l

CapsuleOn Market
Click to view full label

Net Contents

120 Capsule(s)

Serving Size

1 Capsule(s)

Servings Per Container

Not specified

Supplement Form

Capsule

Bar Code (UPC/SKU)

Not specified

Product Version

Not specified

Suggested Use

Suggested Use: Adults take 1 to 2 capsules two to three times daily.

Market Reference

$26.99· 1 listing
  • Marco Mag, 120 Capsules, by Marco Pharma

    Professional Supplement Center
    $26.99Lowest

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • The international law of biotechnology: human rights, trade, patents, health and the environment

    M Herdegen - 2023 - books.google.com

    … The right to health in international human rights instruments: … The right to health in the specific context of medical research … and processes on human health and the environment, the …

    202320 citations
  • Harmonised information exchange between decentralised food composition database systems

    A Kadvan - 2010 - academia.edu

    … current public health and nutrition issues • Major public health/… compounds in foods and supplements • New data on … interfaces for dietary assessment and health applications. 2 3 …

    2010
  • The cambridge handbook of public-private partnerships, intellectual property governance, and sustainable development

    M Chon, P Roffe, A Abdel-Latif - 2018 - books.google.com

    … Her graduate studies focused on health behavior, health education, and health communications. She has been an associate at a digital health company reviewing mobile health …

    201817 citations
  • Take me to your liter: Politics, power, and public-private partnerships with the sugar-sweetened beverage industry in the post-2015 development agenda

    CW Moscetti, AL Taylor - Washington International Law …, 2015 - digitalcommons.law.uw.edu

    … health PPPs between 1982 and 2003. Many of these PPPs were with pharmaceutical and medical device companies, who emerged as the first logical partners to advance global health…

    201512 citations
  • Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield …

    BP Falit - Seton Hall Law Review, 2007 - scholarship.shu.edu

    … pharmaceutical companies are being put to a cruel choice between optimally advancing the medical … As pharmaceutical companies have little incentive to design suboptimal protocols …

    200715 citations
  • Pharmaceutical patent bargains: The brazilian experience

    B Meyerhof Salama, D Benoliel - Cardozo Journal of International …, 2010 - papers.ssrn.com

    … pharmaceutical companies on medicines distributed in Brazil’s public health system.This aggressive behavior was made possible primarily because of the country’s credible threat of …

    201029 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2013-09-25. DSLD Label ID: 25331. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.